iiinova — where your digital self keeps evolving

Amesh Adalja @ameshaa.bsky.social · 13/10/2026

Measles Update October 12, 2026: 6th death

Amesh Adalja @ameshaa.bsky.social · 12/10/2026

The open questions related to the Russian pneumonia death

020

Amesh Adalja @ameshaa.bsky.social · 09/10/2026

In this TV interview I discuss the need for Russian transparency surrounding the pneumonia death in Siberia. It is important to know how this woman was infected and what killed her. What was tested for? What was ruled out? What is pending?

000

Amesh Adalja @ameshaa.bsky.social · 08/10/2026

Russian Unexplained Pneumonia Update (10/7/2026)

131

Amesh Adalja @ameshaa.bsky.social · 07/10/2026

Update on the Siberian Pneumonia Death (10/6/2026)

Amesh Adalja @ameshaa.bsky.social · 05/10/2026

In this TV interview I discuss the suspected “plague” incident in Russia. The response is incongruent with plague and there is a real need for transparency

052

Amesh Adalja @ameshaa.bsky.social · 03/10/2026

PA State Rep Bernstine and the primitive thinking on AIDS that Susan Sontag warned about

Amesh Adalja @ameshaa.bsky.social · 02/10/2026

Rejecting science for beets and watermelons: The New Dark Ages

Amesh Adalja @ameshaa.bsky.social · 01/10/2026

Measles Update September 30, 2026

Amesh Adalja @ameshaa.bsky.social · 01/10/2026

Hepatitis C Cure & Pre-authorization Politics

Amesh Adalja @ameshaa.bsky.social · 30/09/2026

Americans have historically embraced new technologies. The turn against mRNA vaccine technology is one exception that portends a reversal that will lower our standard of living

000

Amesh Adalja @ameshaa.bsky.social · 30/09/2026

Use GMO mosquitos in Florida to combat dengue

Amesh Adalja @ameshaa.bsky.social · 24/09/2026

The FDA commissioner nominee is RFK-approved and was central to the anti-vaccine executive order

000

Amesh Adalja @ameshaa.bsky.social · 23/09/2026

Measles Update September 22, 2026

Amesh Adalja @ameshaa.bsky.social · 22/09/2026

Measles update September 21, 2026: watermelon, beets and peppers are not a solution but a return of the primitive

121

Amesh Adalja @ameshaa.bsky.social · 21/09/2026

Technological asymmetry and AI Biodefense

131

Amesh Adalja @ameshaa.bsky.social · 19/09/2026

Politics and the changing of measles death definitions

002

Amesh Adalja @ameshaa.bsky.social · 16/09/2026

Measles update September 15, 2026

043

Amesh Adalja @ameshaa.bsky.social · 11/09/2026

Explaining Pennsylvania’s measles deaths

011

Amesh Adalja @ameshaa.bsky.social · 10/09/2026

Innovative Use of Pittsburgh EMS Services to Proactively Vaccinate against hepatitis A and test for hepatitis C

Amesh Adalja @ameshaa.bsky.social · 10/09/2026

A paramedic is a trained clinician who already goes where people are. Pittsburgh EMS innovated and proactively put hepatitis A vaccine in their hands in 2019 and hep C tests in 2024. New @centerforhealthsecurity.org SHIELD brief I coauthored shield.centerforhealthsecurity.org/sites/defaul...

Amesh Adalja @ameshaa.bsky.social · 04/09/2026

Pennsylvania Measles Update September 4, 2026

000

Amesh Adalja @ameshaa.bsky.social · 04/09/2026

CDC has always deferred to state death classifications. Refusing to count two Lancaster measles deaths breaks that norm, whatever the coroner’s exact wording. I told The Hill the agency is compromised and damaged by design. www.dropbox.com/scl/fi/omvgl...

020

Amesh Adalja @ameshaa.bsky.social · 03/09/2026

September 3, 2026 Pennsylvania Measles Update

Amesh Adalja @ameshaa.bsky.social · 03/09/2026

Pennsylvania left the vacuum. RFK Jr’s CDC filled it by removing the two deaths from the national tally pending review. A count that can be edited while under review is no longer a count. Quoted in The BMJ. www.dropbox.com/scl/fi/3vraq...

000

Amesh Adalja @ameshaa.bsky.social · 02/09/2026

Tecovirimat’s EA-IND paperwork became its own barrier to treatment in 2022. Administrative complexity is a distribution failure. New @centerforhealthsecurity.org brief I co-authored: shield.centerforhealthsecurity.org/sites/defaul...

011

Amesh Adalja @ameshaa.bsky.social · 02/09/2026

In this TV interview I discuss how the information vacuum created by Pennsylvania has been filled by RFK Jr’s nihilist disinformation brigade

032

Amesh Adalja @ameshaa.bsky.social · 01/09/2026

Pennsylvania Measles Update August 31, 2026

000

Amesh Adalja @ameshaa.bsky.social · 31/08/2026

Feelings aren’t a valid basis for changing how we use technologies such as vaccines

Amesh Adalja @ameshaa.bsky.social · 31/08/2026

Hauntings by the Ghost of Maurice Hilleman, one of the greatest vaccine scientist to ever live

000

Amesh Adalja @ameshaa.bsky.social · 30/08/2026

The Promise of an mRNA influenza vaccine

000

Amesh Adalja @ameshaa.bsky.social · 30/08/2026

Benefits of Remdesivir in Kidney Transplant patients with COVID

Amesh Adalja @ameshaa.bsky.social · 29/08/2026

In this TV interview I discuss how disinformation has been basically invited into Pennsylvania with the poor public health communication from the state regarding the measles-associated deaths

161

Amesh Adalja @ameshaa.bsky.social · 29/08/2026

In this TV interview I discuss how conflicting information and a lack of information created a void that lead to a flurry of disinformation

011

Amesh Adalja @ameshaa.bsky.social · 29/08/2026

PA Measles Update Aug 28,2026

000

Amesh Adalja @ameshaa.bsky.social · 28/08/2026

The Netflix model for antibiotics

Amesh Adalja @ameshaa.bsky.social · 28/08/2026

Pennsylvania Measles Update (8/27/26)

000

Amesh Adalja @ameshaa.bsky.social · 26/08/2026

Measles update: transparency is key

071

Amesh Adalja @ameshaa.bsky.social · 20/08/2026

In this TV interview I discuss some myths and facts about COVID-19

041

Amesh Adalja @ameshaa.bsky.social · 19/08/2026

In this TV interview I discuss new tools for COVID-19 that minimize its disruptive effect

000

Amesh Adalja @ameshaa.bsky.social · 15/08/2026

The challenge of anti-fungal treatments: Last of Us reaction

Amesh Adalja @ameshaa.bsky.social · 14/08/2026

The latest on Cyclospora as well as the Vibrio vulnificus risk